The potential role of Akt phosphorylation in human cancers

Area of Science:

• Molecular Biology
• Oncology
• Biochemistry

Background:

• Akt/protein kinase B (PKB) is a key serine/threonine kinase regulating cell growth, proliferation, and survival.
• Akt activation occurs via phosphorylation at threonine 308 (Thr308) and serine 473 (Ser473).
• Akt2 amplification/overexpression is observed in various cancers, but phosphorylated Akt (P-Akt) activation is more clinically relevant.

Purpose of the Study:

• To review the prognostic and predictive significance of Akt phosphorylation in human malignancies.
• To highlight the clinical relevance of P-Akt in cancers like breast, prostate, and lung cancer.
• To address the need for assay standardization before P-Akt assessment can be used in routine clinical practice.

Main Methods:

• Literature review of studies investigating Akt phosphorylation in cancer.
• Analysis of existing data on the role of P-Akt in various cancer types.
• Evaluation of different assay methodologies used for P-Akt detection.

Main Results:

• Akt phosphorylation demonstrates prognostic and/or predictive value in breast, prostate, and non-small cell lung cancer.
• Evidence suggests a role for P-Akt in endometrial, pancreatic, gastric, tongue, and renal cancers.
• Diverse assay methodologies have been employed, leading to variability in results.

Conclusions:

• Phosphorylated Akt is a clinically significant marker in multiple human cancers.
• Standardization of assay methodologies for P-Akt is critical for its integration into clinical practice.
• Further research is needed to establish reliable and consistent methods for P-Akt assessment.